07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Title</strong>: Dopaminergic modulation of nitric oxide synthase activity in the nucleus accumbens:<br />

Histochemical analysis of regional subdivisions<br />

Authors: *K. E. HOQUE, R. P. INDORKAR, S. SAMMUT, A. R. WEST;<br />

Rosalind Franklin Univ., North Chicago, IL<br />

<strong>Abstract</strong>: The integration of motivational processes within limbic and basal ganglia circuits is<br />

vital <strong>for</strong> normal cognition and goal-directed behavior. The nucleus accumbens (NAc) serves as<br />

an essential functional interface between these two systems. Nitric oxide (NO) is a gaseous<br />

neurotransmitter synthesized by aspiny interneurons containing neuronal NO synthase (nNOS).<br />

nNOS activity in the striatal complex can be detected with NADPH-diaphorase staining, a<br />

histochemical technique that utilizes the NADPH reducing activity of nNOS in fixed tissue.<br />

nNOS activation in the striatal complex is believed to be NMDA receptor dependent and<br />

regulated by activation of dopamine D1 and D2 like receptors. In this study, nNOS activity was<br />

determined using optical density measures of NADPH-diaphorase staining pre<strong>for</strong>med in<br />

subdivisions (core, medial shell, intermediate shell and lateral shell) of the NAc. Awake<br />

behaving rats received i.p. injections of either saline, the D1 receptor agonist SKF 81297, the D1<br />

receptor antagonist SCH 23390 followed by SKF 81297, or the nNOS inhibitor N G -propyl-Larginine<br />

(NPA) followed by SKF 81297, approximately 25 minutes prior to harvesting the brain<br />

<strong>for</strong> staining and analysis. In saline treated animals a distinct medial-lateral histochemical<br />

gradient of NADPH-diaphorase staining was observed. This gradient was characterized by<br />

moderate NADPH-diaphorase staining in the core and medial shell and robust staining in the<br />

intermediate and lateral shell which was approximately three-fold higher than more medial<br />

subregions. SKF 81297 administration preferentially increased NADPH-diaphorase staining twofold<br />

in the medial shell. Pretreatment with both SCH 23390 and NPA attenuated the SKF 81297induced<br />

increase in NADPH-diaphorase staining in the medial shell and decreased staining in the<br />

intermediate shell as compared to saline controls. These observations demonstrate that nNOS<br />

activity measured in regionally distinct populations of NOS interneurons in the NAc is<br />

differentially modulated by D1 receptor activation. Similar studies assessing the impact of<br />

glutamatergic and D2 receptor activation on nNOS activity in NAc subregions are ongoing.<br />

Further characterization of the regulation of NOS activation in NAc subregions may facilitate the<br />

development of novel pharmacotherapies <strong>for</strong> treating disorders of cognition and motivation.<br />

Disclosures: K.E. Hoque, None; R.P. Indorkar, None; S. Sammut, None; A.R. West, None.<br />

Poster<br />

273. Basal Ganglia: Transmitters and Neuromodulation I<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 273.3/II18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!